ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
BC Cancer Agency · University of British Columbia · +10 more institutions
Abstract
Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described.
We sequenced the whole transcriptomes of 18 ovarian clear-cell carcinomas and 1 ovarian clear-cell carcinoma cell line and found somatic mutations in ARID1A (the AT-rich interactive domain 1A [SWI-like] gene) in 6 of the samples. ARID1A encodes BAF250a, a key component of the SWI–SNF chromatin remodeling complex. We sequenced ARID1A in an additional 210 ovarian carcinomas and a second ovarian clear-cell carcinoma cell line and measured BAF250a expression by means of immunohistochemical analysis in an additional 455 ovarian carcinomas.
Citation impact
- FWCI
- 51.31
- Percentile
- 100%
- References
- 36
Authors
44Topics & keywords
- ARID1A
- Clear cell carcinoma
- Clear cell
- Cancer research
- Ovarian cancer
- Serous fluid
- Endometriosis
- Carcinoma
Funding
- SSanofi
- GCGenome Canada
- CMCanada's Michael Smith Genome Sciences Centre
- OCOvarian Cancer Canada
- MSMichael Smith Health Research BC
- UOUniversity of British Columbia
- NINational Institutes of HealthAwards: RO1CA129080, RO1CA103937
- CICanadian Institutes of Health Research
- MRMedical Research Council
- NHNational Health and Medical Research Council
- CCCancer Council Tasmania
- NCNational Cancer InstituteAwards: RO1CA129080, RO1CA103937
- MRMedical Research and Materiel CommandAward: DAMD17-O1-1-0729